gabapentin and GPT/montelukast combination in comparison with dextromethorphan (DXM) for the improvement of COVID-19-related cough. Dear Editor: We read the
COVID Treatment, AZITHROMYCIN (IV). 22, BENZONATATE 100 MG CAP, COVID Cough, BENZONATATE. 23, BENZONATATE 100 MG CAPSULE, COVID Cough, BENZONATATE. 24, BREO
The effectiveness of gabapentin and gabapentin/montelukast combination compared with dextromethorphan in the improvement of COVID-19- related cough: A
Management of COVID-19 associated cough, a common complication of COVID-19 pneumonia, has presented challenges for healthcare providers. Lidocaine, gabapentin, ipratropium and tiotropium, inhaled morphine, and aprepitant have been studied in treatment of chronic cough and have been suggested as potential options for management of COVID-19 cough.1.
Higher dose methylprednisolone and low-dose dexamethasone treatments in patients with COVID Chronic Cough COPD Critical Care Cystic
Gabapentin and pregabalin have been effective in managing chronic refractory cough caused by Post Covid Syndrome, but more research is needed to
The effectiveness of gabapentin and gabapentin/montelukast combination compared with dextromethorphan in the improvement of COVID-19- related cough: A
by CR Guo 2024 Cited by 5cough symptoms in COVID-19 patients. However, it is not Smith, J. A. Gabapentin for refractory chronic cough. Lancet 381
by WJ Song 2024 Cited by 336Although neuromodulators such as gabapentin or opioids might be considered for acute and chronic COVID-19 cough, we discuss the possible mechanisms of COVID-19
Comments